1. stacworkman
2. aquaman00
3. sandyhumming
1.stacworkman 11/01/2018
Unum Therapeutics to Present Preliminary Results from Ongoing Phase 1 Studies ATTCK-20-03 and ATTCK-17-01 at the 2018 ASH Annual Meeting
2.aquaman00 04/23/2018
Morgan Stanley initiates coverage with Overweight rating, $20 PT
3.stacworkman 05/14/2018
Reports Q1 EPS loss of $0.66
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW